GeneChem Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 8
Professionals
  • Investments
  • 91
  • Portfolio
  • 13
  • Exits
  • 50
Exits

GeneChem General Information

Description

Founded in 1997, GeneChem is a manager of focused biotechnology venture capital funds based in Montreal, Canada. It seeks to invest in companies involved in drug discovery and development.

Contact Information

Year Founded
1997
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Mezzanine
Primary Office
  • 1, Westmount Square
  • Suite 800
  • Montreal, Quebec H3Z 2P9
  • Canada
+1 (514) 000-0000

GeneChem Investments (91)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Giiant Pharma 30-Jun-2021 Seed Round 000.00 Drug Discovery Pre-Clinical Trials 000000 000000 00.0
000000000 08-Sep-2020 00000 00000 0000 Drug Discovery Clinical Trials - General 000000 000000 00.0
00000000 000000000 16-Mar-2020 00000 00000 00.000 Drug Discovery Generating Revenue 000000 000000 00.0
000 000000000000 17-Dec-2018 0000 00000 00000 Drug Delivery Pre-Clinical Trials 00è0 00000000 00.0
000000000 25-Jul-2018 00000 00000 00.000 Drug Discovery Clinical Trials - General 000000 000000 00.0
000000000 21-Mar-2018 00000 00000 00.00 Biotechnology Generating Revenue É00000000 00000000 00.0
0000000000 000000 23-Aug-2017 0000 00000 000 Biotechnology Startup 00è0 00000000 00.0
000000000 11-Jan-2017 0000 00000 000 Biotechnology Generating Revenue É00000000 00000000 00.0
Corbin Therapeutics 09-Jan-2017 Seed Round 00000 Biotechnology Startup
Mperia Therapeutics 12-Sep-2016 Early Stage VC 00000 Biotechnology Startup É00000000 00000000 00.0
You’re viewing 10 of 91 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

GeneChem Exits (50)

Company Name Exit Date Exit Type Exit Size
NuChem Sciences 22-Feb-2019 Buyout/LBO
00000 000000000000 01-Dec-2017 000000000000000000 00000
00000000 000000000 03-Feb-2017 000000000 00000000
000000 000000 02-Jul-2015 000 000.00
00000 000000000000 05-Nov-2014 000 0000
0000000 0000000000 30-Oct-2014 0000000 000000 0000
000000 00000000000 20-Mar-2014 000 00000
00000000 07-Feb-2014 000 0000
Sonexa Therapeutics 01-Jan-2014 Bankruptcy: Liquidation
Mirati Therapeutics 24-Oct-2013 Public Investment 2nd Offering 000.00
You’re viewing 10 of 50 exits. Get the full list »

GeneChem Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

GeneChem Team (14)

Name Title Deals Funds Boards Office
Maxime Pesant Chief Financial Officer, Finance & Partner Montreal, Canada
Élizabeth Douville Ph.D Co-Founder & Managing Partner 0 0 0 Montreal, Canada
Inès Holzbaur Ph.D Co-Founder & Managing Partner 0 0 0 Montreal, Canada
Louis Lacasse General Partner 0 0 0 Montreal, Canada
Martial Lacroix Ph.D General Partner 0 0 Montreal, Canada
You’re viewing 5 of 14 team members. Get the full list »

GeneChem Co-Investors (15)

Name With Exits Lead Partner Series Industry
Accel-Rx 2 0 Series chart Industry bar
Anges Québec 0 0 Series chart Industry bar
Anges Québec Capital 0 0 Series chart Industry bar
Fonds de solidarité FTQ 0 0 Series chart Industry bar
Genesys Capital 0 0 Series chart Industry bar
You’re viewing 5 of 15 co-investors. Get the full list »